Skip to main content

Table 1 Occurrence of S. maltophilia biofilm in relation to clinical source

From: Evaluation of antibacterial activity of five biocides and the synergistic effect of biocide/EDTA combinations on biofilm-producing and non-producing Stenotrophomonas maltophilia strains isolated from clinical specimens in Iran

Clinical source (no. of isolates)

No. (%) of isolates with biofilm phenotype

None

Weak

Intermediate

Strong

Blood culture (82)

4 (4.1)

3 (3.09)

39 (40.2)

36 (37.1)

Urine culture (1)

–

–

–

1 (1.03)

Trachea culture (6)

–

2 (2.06)

1 (1.03)

3 (3.09)

BAL (3)

–

1 (1.03)

–

2 (2.06)

Eye discharge culture (2)

–

–

–

2 (2.06)

Sputum (2)

–

1 (1.03)

1 (1.03)

–

Ascites (1)

–

–

–

1 (1.03)

Total (97)

4 (4.1)

7 (7.2)

41 (42.3)

45 (46.4)

  1. BAL bronchoalveolar lavage